GENEVA--(BUSINESS WIRE)-- Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it will participate in the following conferences:

May 14, 2019
Bank of America Merrill Lynch Healthcare Conference
Las Vegas

June 5, 2019
Jefferies 2019 Global Healthcare Conference
New York City

Alcon CEO David Endicott and CFO Tim Stonesifer will speak at both conferences. Presentation materials will be provided on Alcon’s investor website at www.investor.alcon.com.

Disclaimer

This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Alcon. This publication may contain certain forward-looking statements concerning the Company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the Company to be materially different from those expressed or implied by such statements. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update these forward-looking statements.

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Connect with us on
Facebook
LinkedIn

View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005799/en/

Investor Relations
Christina Cheng
+ 41 589 112 110 (Geneva)
+ 1 817 615 2789 (Fort Worth)
[email protected]

Media Relations
Wes Warnock
+ 41 589 112 111 (Geneva)
+ 1 817 615 2501 (Fort Worth)
[email protected]

Source: Alcon Inc. Investors